ReThink Medical

ReThink Medical is a disruptive player in the healthcare industry, specializing in continuous non-invasive monitoring for heart failure patients. The company's flagship product, CorBand™, a wrist-worn monitoring device, harnesses state-of-the-art algorithms and artificial intelligence to predict and prevent heart failure hospitalizations. Founded in 2010, ReThink Medical has successfully positioned itself at the intersection of medical devices and digital health. The company's recent $3.50M Series A investment on 01 May 2017 garnered support from notable firms such as LaunchCapital, Emergent Medical Partners, Norwich Ventures, and テルモ（株）. Hailing from the United States, ReThink Medical's core focus lies in leveraging compliance-centric continuous physiologic monitoring and machine learning to revolutionize traditional healthcare approaches. With an emphasis on proactive management and wearable technology, ReThink Medical's innovations hold the potential to not only enhance the quality of life for heart failure patients but also significantly reduce healthcare costs.